Amelioration of streptozotocin-induced diabetes in mice with cells derived from human marrow stromal cells

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Zhao, Min ^a   Amiel, Stephanie A ^a   Ajami, Sanaz ^a   Jiang, Jie ^a   Rela, Mohamed ^b   Heaton, Nigel ^b   Huang, Guo Cai ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CELL MARKER; GLUCOSE; INSULIN; MESSENGER RNA; NEUROGENIC DIFFERENTIATION FACTOR; NEUROGENIN 3; OCTAMER TRANSCRIPTION FACTOR 4; SULFONYLUREA RECEPTOR 1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR SOX2; ABC TRANSPORTER; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DRUG RECEPTOR; HOMEODOMAIN PROTEIN; INSULIN PROMOTER FACTOR 1; INWARDLY RECTIFYING POTASSIUM CHANNEL; NERVE PROTEIN; NEUROD1 PROTEIN, HUMAN; NEUROG3 PROTEIN, HUMAN; STREPTOZOCIN; SULFONYLUREA RECEPTOR; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; ELECTRON MICROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; ANIMAL; BONE MARROW CELL; CELL TRANSPLANTATION; CYTOLOGY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; METABOLISM; STROMA CELL;

MUS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MARROW CELLS; CELL TRANSPLANTATION; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; HOMEODOMAIN PROTEINS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; NERVE TISSUE PROTEINS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; STREPTOZOCIN; STROMAL CELLS; TRANS-ACTIVATORS;

EID: 50549094994     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002666     Document Type: Article

References (51)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, et al. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using aglucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-8.
2. Krebsbach PH, Kuznetsov SA, Bianco P, Robey PG (1999) Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med 10: 165-81.
3. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, et al. (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369-77.
4. Villaron EM, Almeida J, Lopez-Holgado N, Alcoceba M, Sanchez-AbarcaLi, et al. (2004) Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 89: 1421-7.
5. Moriscot C, de Fraipont F, Richard MJ, Marchand M, Savatier P, et al. (2005) Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells 23: 594-603.
6. Kobune M, Kawano Y, Ito Y, Chiba H, Nakamura K, et al. (2003) Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells. 31: 715-22.
7. Zimmermann S, Voss M, Kaiser S, Kapp U, Waller CF, et al. (2003) Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17: 1146-9.
8. Gumus-Akay G, Unal AE, Bayar S, Karadayi K, Elhan AH, et al. (2007) Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance. Genet Mol Res 6: 41-9.
9. Feldser DM, Greider CW (2007) Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11: 461-9.
10. Armanios M, Greider CW (2005) Telomerase and cancer stem cells. Cold Spring Harb. Symp. Quant. Biol. 70: 205-8.
11. Flores I, Cayuela ML, Blasco MA (2005) Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309: 1253-6.
12. Brazelton TR, Rossi FM, Keshet GI, Blau HM (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290: 1775-9.
13. Corti S, Locatelli F, Donadoni C, Strazzer S, Salani S, et al. (2002) Neuroectodermal and microglial differentiation of bone marros cells in the mouse spinal cord and sensory ganglia. J. Neurosci. Res. 70: 721-33.
14. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR (2000) Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290: 1779-82.
15. Blondheim NR, Levy YS, Ben-Zur T, Burshtetn A, Cherlow T, et al. (2006) Human mesenchymal stem cells express neural genes, suggesting a neural predisposition. Stem Cells Dev 15: 141-64.
16. Yamada Y, Takakura N (2006) Physiological pathway of differentiation of hematopoietic stem cell population into mural cells. J. Exp. Med. 203: 1055-65.
17. Pallante BA, Duignan I, Okin D, Chin A, Bressan MC, et al. (2007) Bone marrow Oct3/4+ cells differentiate into cardiac myocytes via age-dependent paracrine mechanisms. Circ. Res. 100: e1-11.
18. Iwata H, Sata M (2007) Potential contribution of bone marrow-derived precursors to vascular repair and lesion formation: lessons from animal models of vascular diseases. Front. Biosci. 112: 4157-67.
19. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, et al. (1999) Bone marrow as a potential source of hepatic oval cells. Science 284: 1168-70.
20. Ianus A, Holz GG, Theise ND, Hussain MA (2003) In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest 111: 843-50.
21. Tayaramma T, Ma B, Rohde M, Mayer H (2006) Chromatin-remodeling factors allow differentiation of bone marrow cells into insulin-producing cells. Stem Cells 24: 2858-67.
22. Timper K, Seboek D, Eberhardt M, Linscheid P, Christ-Crain M, et al. (2006) Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem. Biophys. Res. Commun. 341: 1135-40.
23. Karnieli O, Izhar-Prato Y, Bulvik S, Efrat S (2007) Generation of Insulin-producing Cells From Human Bone Marrow Mesenchymal Stem Cells By Genetic Manipulation. Stem Cells 25: 2837-44.
24. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, et al. (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. U.S.A. 103: 17438-43.
25. Zhao M, Amiel SA, Christie MR, Rela M, Heaton N, et al. (2005) Insulin-producing cells derived from human pancreatic non-endocrine cell cultures reverse streptozotocin-induced hyperglycaemia in mice. Diabetologia 48: 2051-61.
26. Hobbs SM (1997) Artificial DNA; bicistronic eukaryotic expression vector pIRES-N1 submitted to EMBL/GenBank/DDBJ databases. AC no.: Y11035.
27. Zhao M, Christie MR, Heaton N, George S, Amiel S, et al. (2002) Amelioration of streptozotocin induced diabetic mice with human islet cells derived from long term culture in vitro. Transplantation 73: 1454-1460.
28. Pascucci L, Mercati F, Gargiulo AM, Pedini V, Sorbolini S, et al. (2006) CD34 glycoprotein identifies putative stem cells located in the isthmic region of canine hair follicles. Vet. Dermatol. 17: 244-51.
29. Morrison GM, Brickman JM (2006) Conserved roles for Oct4 homologues in maintaining multipotency during early vertebrate development. Development 13: 2011-22.
30. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, et al. (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95: 379-91.
31. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, et al. (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17: 126-40.
32. Ellis P, Fagan BM, Magness ST, Hutton S, Taranova O, et al. (2004) SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci 26: 148-65.
33. Kuroda T, Tada M, Kubota H, Kimura H, Hatano SY, et al. (2005) Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 25: 2475-85.
34. Hough SR, Clements I, Welch PJ, Wiederholt KA (2006) Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog. Stem Cells 24: 1467-75.
35. Miller CP, McGehee RE, Habener JF (1994) IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J 13: 1145-56.
36. Moore M, Marcora E, Lee JE, Qiu Y, Samaras S, et al. (1999) The NeuroD1/ BETA2 sequences essential for insulin gene transcription colocalize with those necessary for neurogenesis and p300/CREB binding protein binding. Mol. Cell. Biol. 19: 704-13.
37. Gradwohl G, Dierich A, LeMeur M, Guillemot F (2000) neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl. Acad. Sci. U.S.A. 97: 1607-l1.
38. Nelson SB, Schaffer AE, Sander M (2007) The transcription factors Nkx6.1 and Nkx6.2 possess equivalent activities in promoting beta-cell fate specification in Pdxl+ pancreatic progenitor cells. Development 134: 2491-500.
39. Hall PA, Richards MA, Gregory WM, d'Ardenne AJ, Lister TA, et al. (1998) The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol 154: 223-35.
40. Rajagopal J, Anderson WJ, Kume S, Martinez OI, Melton DA (2003) Insulin staining of ES cell progeny from insulin uptake. Science 299: 363.
41. Zhao M, Amiel SA, Christie MR, Muiesan P, Srinivasan P, et al. (2007) Evidence for the presence of stem cell-like progenitor cells in human adult pancreas. J. of Endocrinology 195: 407-414.
42. Lechner A, Yang YG, Blacken RA, Wang L, Nolan AL, et al. (2004) No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 53: 616-23.
43. Taneera J, Rosengren A, Renstrom E, Nygren JM, Serup P, et al. (2006) Failure of transplanted bone marrow cells to adopt a pancreatic beta-cell fate. Diabetes 55: 290-6.
44. Butler AE, Huang A, Rao PN, Bhushan A, Hogan WJ, et al. (2007) Hematopoietic stem cells derived from adult donors are not a source of pancreatic beta-cells in adult nondiabetic humans. Diabetes 56(7): 1810-6.
45. MacFarlane WM, Chapman JC, Shepherd RM, Hashmi MN, Kamimura N, et al. (1999) Engineering a glucose-responsive human insulin-secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinemic hypoglycemia of infancy. J Biol Chem 274: 34059-66.
46. Huang HP, Liu M, El-Hodiri HM, Chu K, Jamrich M, et al. (2000) Regulation of the pancreatic islet-specific gene BETA2 (neuroD1) by neurogenin 3. Mol Cell Biol 20: 3292-307.
47. Kaneto H, Nakatani Y, Miyatsuka T, Matsuoka TA, Matsuhisa M, et al. (2005) PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance. Diabetes 54: 1009-22.
48. Hauge-Evans AC, Squires PE, Persaud SJ, Jones PM (1999) Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes 48: 1402-8.
49. Shiota C, Larsson O, Shelton KD, Shiota M, Efanov AM, et al. (2002) Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J Biol Chem 277: 37176-83.
50. Fujikawa T, Oh SH, Pi L, Hatch HM, Shupe T, et al. (2005) Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol 166: 1781-91.
51. Jiang J, Best S, Menzel S, Silver N, Lai MI, et al. (2006) cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 108: 1077-83.